Finally, we also observed that within the CIS/MS group, EBV VCA IgM positivity was associated with increased HLA-DR expression and expression of markers of a T-bet+ differentiation pathway, including CXCR3, on IgM+ MBCs. The gene discussed is CD40LG; the disease is in situ carcinoma.